Skip to main content
. Author manuscript; available in PMC: 2018 Feb 7.
Published in final edited form as: J Chem Inf Model. 2017 Apr 3;57(4):875–882. doi: 10.1021/acs.jcim.6b00754

Figure 4.

Figure 4

Confirmation of bioactivity against the IRE1α/XBP1 pathway, a branch of the UPR. The HT1080 (human fibrosarcoma) cell line was stably transduced with an XBP1-luciferase reporter construct. (top) Generated SMILES expressions, (middle) structures, and (bottom) dose–response curves showing inhibitory action relative to CMV control toward IRE1α/XBP1 are presented for the two identified inhibitors, (A) STF-021898 and (B) STF-046304.